RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. ...
As more companies market their tests and related products, gastroenterologists are faced with trying to incorporate a technology that’s not quite ready for the clinic.
Sprout Health Serves as Case Study for Provider Model Structure, Program Costs, and FDA-vs-Compounded Disclosure Standards ...
The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...
China's drug regulator has also accelerated approvals of domestically developed innovative products. The National Medical ...
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly ...
BHVN’s investment case definitely weakened after Opakalim’s Phase 2 MDD miss. This also means they’ll discontinue their ...
Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...
India’s pharmaceutical market is currently valued at around $60 billion and is expected to reach about $130 billion by 2030, according to the Department of Pharmaceuticals. Longer-term projections by ...
Morning Overview on MSN
New 3D-print material pushes artificial organs a step closer
Researchers have unveiled a new 3D‑printable material that can be stretched, sutured, and implanted, edging artificial organs ...
AB Science receives US patent for masitinib to treat sickle cell disease: Paris Friday, December 26, 2025, 14:00 Hrs [IST] AB Science SA, a pharmaceutical company specializing in ...
Adaptive Biotechnologies Corporation is rated Hold as MRD segment momentum offset by competitive & valuation concerns. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback